Hiroki Mutoh

Dr. Hiroki Mutoh

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2014 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
GSGregory Scott
Gregory Scott
EFErik D. Fagerholm
Erik D. Fagerholm
HMHiroki Mutoh
Hiroki Mutoh
RLRobert Leech
Robert Leech
DSDavid J. Sharp
David J. Sharp
TKThomas Knöpfel
Thomas Knöpfel
Complex cognitive processes require neuronal activity to be coordinated across multiple scales, ranging from local microcircuits to cortex-wide networks. However, multiscale cortical dynamics are not well understood because few experimental approaches have provided sufficient support for hypotheses involving multiscale interactions. To address these limitations, we used, in experiments involving mice, genetically encoded voltage indicator imaging, which measures cortex-wide electrical activity at high spatiotemporal resolution. Here we show that, as mice recovered from anesthesia, scale-invariant spatiotemporal patterns of neuronal activity gradually emerge. We show for the first time that this scale-invariant activity spans four orders of magnitude in awake mice. In contrast, we found that the cortical dynamics of anesthetized mice were not scale invariant. Our results bridge empirical evidence from disparate scales and support theoretical predictions that the awake cortex operates in a dynamical regime known as criticality. The criticality hypothesis predicts that small-scale cortical dynamics are governed by the same principles as those governing larger-scale dynamics. Importantly, these scale-invariant principles also optimize certain aspects of information processing. Our results suggest that during the emergence from anesthesia, criticality arises as information processing demands increase. We expect that, as measurement tools advance toward larger scales and greater resolution, the multiscale framework offered by criticality will continue to provide quantitative predictions and insight on how neurons, microcircuits, and large-scale networks are dynamically coordinated in the brain.

18 January 2022 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
HMHiroki Mutoh
Hiroki Mutoh
KAKazushi Aoto
Kazushi Aoto
TMTakehiro Miyazaki
Takehiro Miyazaki
AFAtsuo Fukuda
Atsuo Fukuda
HSHirotomo Saitsu
Hirotomo Saitsu

Verified
Journal Article
Open access
PDF file
KAKazushi Aoto
Kazushi Aoto
STShuji Takabayashi
Shuji Takabayashi
HMHiroki Mutoh
Hiroki Mutoh
HSHirotomo Saitsu
Hirotomo Saitsu
Specific antibodies are necessary for cellular and tissue expression, biochemical, and functional analyses of protein complexes. However, generating a specific antibody is often time-consuming and effort-intensive. The epitope tagging of an endogenous protein at an appropriate position can overcome this problem. Here, we investigated epitope tag position using AlphaFold2 protein structure prediction and developed Flag/DYKDDDDK tag knock-in CaMKIIα and CaMKIIβ mice by combining CRISPR-Cas9 genome editing with electroporation (i-GONAD). With i-GONAD, it is possible to insert a small fragment of up to 200 bp into the genome of the target gene, enabling efficient and convenient tagging of a small epitope. Experiments with commercially available anti-Flag antibodies could readily detect endogenous CaMKIIα and β proteins by Western blotting, immunoprecipitation, and immunohistochemistry. Our data demonstrated that the generation of Flag/DYKDDDDK tag knock-in mice by i-GONAD is a useful and convenient choice, especially if specific antibodies are unavailable.

15 April 2026 in Epilepsia
Verified
Journal Article
Open access
HMHiroki Mutoh
Hiroki Mutoh
KAKazushi Aoto
Kazushi Aoto
AFAtsuo Fukuda
Atsuo Fukuda
HSHirotomo Saitsu
Hirotomo Saitsu
Objective: Pathogenic variants in the calcium/calmodulin‐dependent protein kinase II B gene ( CAMK2B ) have been associated with neurodevelopmental disorders, including epilepsy, yet the mechanisms underlying cortical dysfunction remain largely unclear. Building on our previous clinical report of a patient carrying the CaMKIIβ P213L variant and our prior characterization of the corresponding mouse models, we investigated how P213L‐associated CaMKIIβ insufficiency alters cortical network dynamics and susceptibility to pentylenetetrazol (PTZ)–induced seizures in vivo. Methods: We performed electroencephalographic recordings for CaMKIIβ P213L knock‐in mice under baseline and pharmacological modulation. Susceptibility to seizure induction by the chemoconvulsant PTZ was assessed. Cortical CaMKIIβ expression and Thr287 phosphorylation levels were quantified and compared to those in CaMKIIβ knockout mice. Results: Heterozygous and homozygous knock‐in mice exhibited aberrant low‐gamma (20–50 Hz) oscillations during resting state with behavioral immobility. These aberrant low‐gamma oscillations were sensitive to γ‐aminobutyric acid (GABA)‐ergic modulation: pentylenetetrazol (PTZ) induced a downward shift in the gamma‐band peak frequency, whereas isoflurane, diazepam, and valproic acid suppressed the aberrant low‐gamma oscillations. PTZ administration increased seizure severity in both heterozygous and homozygous knock‐in mice, but lethality occurred only in homozygous mice. We quantified cortical CaMKIIβ expression and Thr287 phosphorylation, both of which were reduced in knock‐in mice. Knockout mice recapitulated the aberrant low‐gamma oscillations and their pharmacological modulation observed in knock‐in mice, supporting the role of CaMKIIβ insufficiency in driving the phenotype. Significance: These findings suggest that CaMKIIβ insufficiency disrupts cortical excitatory–inhibitory balance, leading to the aberrant low‐gamma oscillations and increased seizure susceptibility. Our findings establish a mechanistic link between CaMKIIβ deficiency and epilepsy‐related phenotypes in neurodevelopmental disorders. The P213L variant represents a loss‐of‐function variant with reduced CaMKIIβ expression and phosphorylation, and provides a valuable model for investigating disease mechanisms and developing potential therapeutic strategies.